Cargando…
The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children. Success of current therapies is still limited and outcome is particularly poor for metastatic alveolar rhabdomyosarcoma (aRMS). We previously identified the proprotein convertase furin as potential target for specific drug de...
Autores principales: | Jaaks, Patricia, Meier, Gianmarco, Alijaj, Nagjie, Brack, Eva, Bode, Peter, Koscielniak, Ewa, Wachtel, Marco, Schäfer, Beat W., Bernasconi, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363546/ https://www.ncbi.nlm.nih.gov/pubmed/27572312 http://dx.doi.org/10.18632/oncotarget.11648 |
Ejemplares similares
-
The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion
por: Jaaks, Patricia, et al.
Publicado: (2016) -
The proprotein convertase furin is required for trophoblast syncytialization
por: Zhou, Z, et al.
Publicado: (2013) -
OFF-State-Specific Inhibition of the Proprotein Convertase
Furin
por: Dahms, Sven O., et al.
Publicado: (2021) -
Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality
por: Fernandez, C., et al.
Publicado: (2018) -
Myeloid cell expressed proprotein convertase FURIN attenuates inflammation
por: Cordova, Zuzet Martinez, et al.
Publicado: (2016)